Garry Menzel Net Worth & Insider Trades

Garry Menzel - President and CEO, Tcr2 Therapeutics Inc

As of December 19, 2022

What is Garry Menzel's Net Worth?

The current estimated net worth of Tcr2 Therapeutics Inc's President and CEO, Garry Menzel, is estimated to be about $201.04K . Garry Menzel owns about 309,680 units of Tcr2 Therapeutics Inc common stock. In the last 3 years at Tcr2 Therapeutics Inc, Garry Menzel has sold an estimated value of $101.87K worth.

What is Garry Menzel's Past Insider Trading?

Garry Menzel's largest sale order was 31,938 units , worth over $35.03K on December 13, 2022. In total, Garry Menzel has made about 14 transactions over 3 years of their time at Tcr2 Therapeutics Inc. Garry Menzel usually trades in December, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Garry Menzel's' Mailing Address?

  • Mailing address is C/o Regulus Therapeutics Inc. 3545 John Hopkins Court Suite 210 San Diego CA 92121 CA

What are Tcr2 Therapeutics Inc's Past Insider Trades?

Tcr2 Therapeutics Inc's most recent insider trade came on December 13, 2022 by Quintas Alfonso Cardama who sold 13,799 units worth $15.12K . In the last 3 years, insiders at Tcr2 Therapeutics Inc have sold an estimated value of $16.53M and bought an estimated value of $65.28M worth of shares. Insider trading is most common in December, with the busiest year in 2022. The most active traders at the company are Garry Menzel, President and CEO,  Quintas Alfonso Cardama, Chief Medical Officer,  and Angela Justice, Chief People Officer .

TCR2 THERAPEUTICS INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1